Foreign Investments Under Fire in India; Panel Urges Ban on ‘Brownfield’ Buys

Indian policymakers are calling for a blanket ban on new foreign investment in existing domestic pharma companies, cautioning the government that any more takeovers of large manufacturers by outsiders could destroy the benefits flowing from India’s “generic revolution.”
International Pharmaceutical Regulatory Monitor